Abbott profit jumps 68 pct on higher generics sales

July 22 (Reuters) - Abbott Laboratories Inc reported a 68 percent jump in quarterly profit, helped by higher sales of the company's branded generics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.